EAGLE PHARMACEUTICALS INC. - COMMON STOCK

NetDania - New 12 months Low: EAGLE PHARMACEUTICALS INC. - COMMON STOCK

12 12 2023 09:47:38 提供 NetDania Notify

NetDania - New 12 months Low: EAGLE PHARMACEUTICALS INC. - COMMON STOCK

11 12 2023 10:37:01 提供 NetDania Notify

Eagle Pharmaceuticals to Present Abstract on Post-hoc Analysis of Amisulpride at the 77th PGA (PostGraduate Assembly in Anesthesiology) in New York City

06 12 2023 16:05:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: EAGLE PHARMACEUTICALS INC. - COMMON STOCK

29 11 2023 09:45:01 提供 NetDania Notify

Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q

29 11 2023 07:35:00 提供 Nasdaq GlobeNewswire

Eagle Pharmaceuticals Announces Management Change

29 11 2023 07:30:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: EAGLE PHARMACEUTICALS INC. - COMMON STOCK

28 11 2023 09:48:28 提供 NetDania Notify

NetDania - New 12 months Low: EAGLE PHARMACEUTICALS INC. - COMMON STOCK

16 11 2023 11:02:22 提供 NetDania Notify

NetDania - New 12 months Low: EAGLE PHARMACEUTICALS INC. - COMMON STOCK

14 11 2023 11:34:59 提供 NetDania Notify

Eagle Delays Third Quarter 2023 Results and Conference Call

09 11 2023 07:30:00 提供 Nasdaq GlobeNewswire

Eagle Pharmaceuticals to Host Third Quarter 2023 Financial Results on November 9, 2023

08 11 2023 08:30:00 提供 Nasdaq GlobeNewswire

Eagle Pharmaceuticals Granted Patent for PEMFEXY®

24 10 2023 08:40:44 提供 Nasdaq GlobeNewswire

Eagle Pharmaceuticals Granted Unique J-Code and Pass-Through Status for BARHEMSYS® from CMS

23 10 2023 06:50:00 提供 Nasdaq GlobeNewswire

Eagle Pharmaceuticals Awarded First Prize for Poster to Be Presented at the International Society for Anaesthetic Pharmacology 32nd Annual Meeting

04 10 2023 06:50:00 提供 Nasdaq GlobeNewswire

Eagle Pharmaceuticals to Present at the Cantor Global Healthcare Conference 2023

19 9 2023 16:05:00 提供 Nasdaq GlobeNewswire

Eagle Pharmaceuticals to Present CAL02 Trial in Progress at the 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance

11 9 2023 06:50:00 提供 Nasdaq GlobeNewswire

Eagle Pharmaceuticals to Present BYFAVO® (remimazolam) for Injection Abstract at Prestigious Society for Neuroscience in Anesthesiology and Critical Care (SNACC) Conference

30 8 2023 06:50:00 提供 Nasdaq GlobeNewswire

Eagle Pharmaceuticals Announces Positive Type C Meeting with FDA for EA-114, an Estrogen Receptor Antagonist Used in the Treatment of Metastatic Breast Cancer in Post-Menopausal Women

29 8 2023 06:50:00 提供 Nasdaq GlobeNewswire

Eagle Pharmaceuticals to Present at Two Upcoming Healthcare Conferences

22 8 2023 16:05:00 提供 Nasdaq GlobeNewswire

Eagle Pharmaceuticals Reiterates 2023 Adjusted non-GAAP EBITDA and Adjusted non-GAAP E¹ Guidance

17 8 2023 06:50:00 提供 Nasdaq GlobeNewswire